Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Surveillance imaging for lymphoma: pros and cons
Ryan C. Lynch
, Andrew D. Zelenetz
, James O. Armitage
, Kenneth R. Carson
Section of Medical Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
11
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Surveillance imaging for lymphoma: pros and cons'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lymphoma
100%
Surveillance Imaging
100%
Diagnostic Imaging
66%
Clinical Decisions
33%
Clinical Evaluation
33%
Initial Treatment
33%
Overall Survival
33%
Positron Emission Tomography
33%
Relative Risk
33%
Computed Tomography
33%
Clinical Practice Guidelines
33%
Oncologists
33%
Survival Disparities
33%
Lymphoma Subtype
33%
Patient-centered
33%
Complete Remission
33%
Indolent Lymphoma
33%
International Consensus
33%
International Prognostic Index
33%
Routine Imaging
33%
Risk Cost
33%
Relative Benefit
33%
Cost-benefit
33%
Fast Growth Rate
33%
Ionizing Radiation Effects
33%
Aggressive Lymphoma
33%
Long-run Risk
33%
Optimal Duration
33%
Secondary Malignancy
33%
Relative Cost
33%
Optimal Frequency
33%
Medicine and Dentistry
Health Care Cost
100%
Diagnostic Imaging
100%
Positron Emission Tomography
50%
Clinical Trial
50%
Cancer
50%
Overall Survival
50%
Computer Assisted Tomography
50%
Radiation Exposure
50%
Ionizing Radiation
50%
Oncologist
50%
Physical Disease by Body Function
50%
International Prognostic Index
50%
Aggressive Lymphoma
50%